162 related articles for article (PubMed ID: 16432159)
1. Restoration of p53 function for selective Fas-mediated apoptosis in human and rat glioma cells in vitro and in vivo by a p53 COOH-terminal peptide.
Senatus PB; Li Y; Mandigo C; Nichols G; Moise G; Mao Y; Brown MD; Anderson RC; Parsa AT; Brandt-Rauf PW; Bruce JN; Fine RL
Mol Cancer Ther; 2006 Jan; 5(1):20-8. PubMed ID: 16432159
[TBL] [Abstract][Full Text] [Related]
2. C-Terminal p53 Palindromic Tetrapeptide Restores Full Apoptotic Function to Mutant p53 Cancer Cells In Vitro and In Vivo.
Fine RL; Mao Y; Dinnen R; Rosal RV; Raffo A; Hochfeld U; Senatus P; Bruce JN; Nichols G; Wang H; Li Y; Brandt-Rauf PW
Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672645
[TBL] [Abstract][Full Text] [Related]
3. Selective induction of apoptosis through the FADD/caspase-8 pathway by a p53 c-terminal peptide in human pre-malignant and malignant cells.
Li Y; Mao Y; Rosal RV; Dinnen RD; Williams AC; Brandt-Rauf PW; Fine RL
Int J Cancer; 2005 May; 115(1):55-64. PubMed ID: 15645452
[TBL] [Abstract][Full Text] [Related]
4. Correlation between hydrophobic properties and efficiency of carrier-mediated membrane transduction and apoptosis of a p53 C-terminal peptide.
Li Y; Rosal RV; Brandt-Rauf PW; Fine RL
Biochem Biophys Res Commun; 2002 Nov; 298(3):439-49. PubMed ID: 12413961
[TBL] [Abstract][Full Text] [Related]
5. Conformational and molecular basis for induction of apoptosis by a p53 C-terminal peptide in human cancer cells.
Kim AL; Raffo AJ; Brandt-Rauf PW; Pincus MR; Monaco R; Abarzua P; Fine RL
J Biol Chem; 1999 Dec; 274(49):34924-31. PubMed ID: 10574967
[TBL] [Abstract][Full Text] [Related]
6. Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding site.
Do TN; Rosal RV; Drew L; Raffo AJ; Michl J; Pincus MR; Friedman FK; Petrylak DP; Cassai N; Szmulewicz J; Sidhu G; Fine RL; Brandt-Rauf PW
Oncogene; 2003 Mar; 22(10):1431-44. PubMed ID: 12629507
[TBL] [Abstract][Full Text] [Related]
7. Activation of targeted necrosis by a p53 peptide: a novel death pathway that circumvents apoptotic resistance.
Dinnen RD; Drew L; Petrylak DP; Mao Y; Cassai N; Szmulewicz J; Brandt-Rauf P; Fine RL
J Biol Chem; 2007 Sep; 282(37):26675-26686. PubMed ID: 17636258
[TBL] [Abstract][Full Text] [Related]
8. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis.
Pohl U; Wagenknecht B; Naumann U; Weller M
Cell Physiol Biochem; 1999; 9(1):29-37. PubMed ID: 10352342
[TBL] [Abstract][Full Text] [Related]
9. Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction.
Broaddus WC; Liu Y; Steele LL; Gillies GT; Lin PS; Loudon WG; Valerie K; Schmidt-Ullrich RK; Fillmore HL
J Neurosurg; 1999 Dec; 91(6):997-1004. PubMed ID: 10584846
[TBL] [Abstract][Full Text] [Related]
10. Intravenous injection of cycloheximide induces apoptosis and up-regulates p53 and Fas receptor expression in the rat liver in vivo.
Higami Y; Tanaka K; Tsuchiya T; Shimokawa I
Mutat Res; 2000 Dec; 457(1-2):105-11. PubMed ID: 11106802
[TBL] [Abstract][Full Text] [Related]
11. NT4(Si)-p53(N15)-antennapedia induces cell death in a human hepatocellular carcinoma cell line.
Song LP; Li YP; Wang N; Li WW; Ren J; Qiu SD; Wang QY; Yang GX
World J Gastroenterol; 2009 Dec; 15(46):5813-20. PubMed ID: 19998502
[TBL] [Abstract][Full Text] [Related]
12. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas.
Cerrato JA; Khan T; Koul D; Lang FF; Conrad CA; Yung WK; Liu TJ
Int J Oncol; 2004 Feb; 24(2):409-17. PubMed ID: 14719118
[TBL] [Abstract][Full Text] [Related]
13. T11TS Treatment Augments Apoptosis of Glioma Associated Brain Endothelial Cells, Hint Toward Anti-Angiogenic Action in Glioma.
Bhattacharya D; Singh MK; Chaudhuri S; Datta A; Chaudhuri S
J Cell Physiol; 2017 Mar; 232(3):526-539. PubMed ID: 27255231
[TBL] [Abstract][Full Text] [Related]
14. p53 mutant human glioma cells are sensitive to UV-C-induced apoptosis due to impaired cyclobutane pyrimidine dimer removal.
Batista LF; Roos WP; Kaina B; Menck CF
Mol Cancer Res; 2009 Feb; 7(2):237-46. PubMed ID: 19208740
[TBL] [Abstract][Full Text] [Related]
15. Trans-membrane peptide therapy for malignant glioma by use of a peptide derived from the MDM2 binding site of p53.
Yamada S; Kanno H; Kawahara N
J Neurooncol; 2012 Aug; 109(1):7-14. PubMed ID: 22528789
[TBL] [Abstract][Full Text] [Related]
16. A Recombinant Fragment of Human Surfactant Protein D induces Apoptosis in Pancreatic Cancer Cell Lines
Kaur A; Riaz MS; Murugaiah V; Varghese PM; Singh SK; Kishore U
Front Immunol; 2018; 9():1126. PubMed ID: 29915574
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
18. Lovastatin and phenylacetate induce apoptosis, but not differentiation, in human malignant glioma cells.
Schmidt F; Groscurth P; Kermer M; Dichgans J; Weller M
Acta Neuropathol; 2001 Mar; 101(3):217-24. PubMed ID: 11307620
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine.
Roos WP; Batista LF; Naumann SC; Wick W; Weller M; Menck CF; Kaina B
Oncogene; 2007 Jan; 26(2):186-97. PubMed ID: 16819506
[TBL] [Abstract][Full Text] [Related]
20. A novel p53 rescue compound induces p53-dependent growth arrest and sensitises glioma cells to Apo2L/TRAIL-induced apoptosis.
Weinmann L; Wischhusen J; Demma MJ; Naumann U; Roth P; Dasmahapatra B; Weller M
Cell Death Differ; 2008 Apr; 15(4):718-29. PubMed ID: 18202704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
